Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The research, published in the Journal of Endocrinology and Metabolism, found that the peptide had no effect on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no anti-AOD-9604 antibodies were detected in any patients
Related BPC-157 & TB-500 Research Products Researchers interested in BPC-157 + TB-500 Capsules may also explore related research peptide vials, sprays, capsules, blends, and educational resources from Frontier Peptide Labs
BAC water's benzyl alcohol prevents contamination
Loading Phase (Weeks 1-4): 2 to 2.5 mg twice weekly (Monday/Thursday schedule) Maintenance Phase (Weeks 5+): 2 mg once every 7 to 14 days Administration: Subcutaneous injection, location flexible due to systemic distribution Total Cycle: 8 to 12 weeks with 4 to 8 weeks off between cycles The convenience of twice-weekly dosing during loading and weekly or biweekly dosing during maintenance fits easily into Retatrutide schedules
Liposomal delivery is designed to improve absorption compared to standard oral peptides
US$ 20.94
US$ 29.36
US$ 20.48
US$ 26.75
US$ 21.89
US$ 23.06
US$ 25.97
US$ 28.10
US$ 29.65
US$ 21.28
US$ 29.34
US$ 29.20
US$ 21.63
